UPC · NASDAQ
Universe Pharmaceuticals (UPC) Stock Price & Fundamentals
Universe Pharmaceuticals (UPC) closed at $808.48 on Oct 9, 2026, down 0.02% from the previous close of $808.65.
Share price, past year
1Y +6.65%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $808.48 |
| Sep 30, 2026 | $808.14 |
| Aug 31, 2026 | $831.90 |
| Jul 31, 2026 | $810.55 |
| Jun 30, 2026 | $793.98 |
| May 29, 2026 | $851.79 |
| Apr 30, 2026 | $804.89 |
| Mar 31, 2026 | $789.07 |
| Feb 27, 2026 | $742.28 |
| Jan 30, 2026 | $756.01 |
| Dec 31, 2025 | $751.44 |
| Nov 28, 2025 | $740.47 |
| Oct 31, 2025 | $788.01 |
Key statistics
- Market cap
- $455.45M
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- —
- Net income (TTM)
- —
- Shares outstanding
- 563.3K
- Dividend yield
- —
- 52-week range
- $732.37 – $851.79
Universe Pharmaceuticals's market cap is $455.45M, based on a share price of $808.48 and 563.3K shares outstanding as of Sep 30, 2025.
Financials
Universe Pharmaceuticals reported revenue of $17.86B for fiscal 2025, down 22.44% from fiscal 2024.
Universe Pharmaceuticals reported a net loss of $3.67B in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Sep 30, 2025 | $17.86B | −22.4% | −$3.67B | −20.6% | −$8.06 | −$5.32B |
| FY2024ended Sep 30, 2024 | $23.02B | −28.7% | −$8.73B | −37.9% | −$626.96 | −$9.72B |
| FY2023ended Sep 30, 2023 | $32.31B | +80,383.8% | −$6.58B | −20.4% | −$1,089.21 | $1.07B |
| FY2022ended Sep 30, 2022 | $40.14M | −16.3% | −$7.91M | −19.7% | −$1,309.11 | −$1.40M |
| FY2021ended Sep 30, 2021 | $47.98M | +56.3% | $11.32M | 23.6% | $3.58 | −$2.50M |
| FY2020ended Sep 30, 2020 | $30.70M | −7.6% | $7.56M | 24.6% | $0.47 | $6.06M |
| FY2019ended Sep 30, 2019 | $33.23M | — | — | — | $0.47 | $13.12M |
Company profile
- Name
- Universe Pharmaceuticals INC
- Ticker
- UPC
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 265 Jingjiu Avenue, Jinggangshan Econ. And Tech. Dev. Zone, Ji'An, Jiangxi, F4 343100
- Incorporated in
- F4
- Fiscal year ends
- September
- SEC CIK
- 0001809616
Frequently asked questions
What is Universe Pharmaceuticals's stock price?
Universe Pharmaceuticals (UPC) closed at $808.48 on Oct 9, 2026, down 0.02% from the previous close of $808.65.
What is Universe Pharmaceuticals's market cap?
Universe Pharmaceuticals's market cap is $455.45M, based on a share price of $808.48 and 563.3K shares outstanding as of Sep 30, 2025.
How much revenue does Universe Pharmaceuticals make?
Universe Pharmaceuticals reported revenue of $17.86B for fiscal 2025, down 22.44% from fiscal 2024.
Sources and methodology
Fundamentals come from Universe Pharmaceuticals INC's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures